Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease.

Bone Cancer-induced bone disease Mechanical stimulation Multiple Myeloma Skeletal Mechanobiology

Journal

Acta biomaterialia
ISSN: 1878-7568
Titre abrégé: Acta Biomater
Pays: England
ID NLM: 101233144

Informations de publication

Date de publication:
01 01 2021
Historique:
received: 11 07 2020
revised: 05 10 2020
accepted: 27 10 2020
pubmed: 2 11 2020
medline: 15 5 2021
entrez: 1 11 2020
Statut: ppublish

Résumé

Bone continually adapts to changing external loading conditions via (re)modeling (modeling and remodeling) processes. While physical activity is known to beneficially enhance bone mass in healthy individuals, little is known in how physical stimuli affect osteolytic bone destruction in patients suffering from multiple myeloma bone disease. Multiple myeloma (MM) is caused by malignant plasma cells in the bone marrow, shifting the balance in bone remodeling towards massive resorption. We hypothesized that in vivo tibial mechanical loading has anabolic effects in mice with locally injected MOPC315.BM.Luc cells. Conventional microCT analysis revealed enhanced cortical bone mass and microstructure in loaded compared to nonloaded mice. State-of-the-art time-lapse microCT based image analysis demonstrated bone (re)modeling processes at the endosteal and periosteal surfaces as the underlying causes of increased bone mass. Loading prevented the progression and development of osteolytic destruction. Physical stimuli also diminished local MM cell growth and dissemination evidenced by quantification of MM cell-specific immunoglobulin A levels in the serum of mice and by bioluminescence analysis. These data indicate that mechanical loading not only rescues the bone phenotype, but also exerts cell-extrinsic anti-myeloma effects in the MOPC315.BM.Luc model. In conclusion, the use of physical stimuli should be further investigated as an anabolic treatment for osteolytic bone destruction in patients with MM.

Identifiants

pubmed: 33130307
pii: S1742-7061(20)30639-5
doi: 10.1016/j.actbio.2020.10.041
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

247-258

Informations de copyright

Copyright © 2020. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Maximilian Rummler (M)

Research Centre, Shriners Hospital for Children-Canada, Montreal, Canada; Julius Wolff Institute and Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Pediatric Surgery, McGill University, Montreal, Canada.

Fani Ziouti (F)

Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Alice L Bouchard (AL)

Research Centre, Shriners Hospital for Children-Canada, Montreal, Canada; Department of Pediatric Surgery, McGill University, Montreal, Canada.

Andreas Brandl (A)

Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Georg N Duda (GN)

Julius Wolff Institute and Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany.

Bjarne Bogen (B)

Institute of Clinical Medicine, University of Oslo and Department of Immunology, Oslo University Hospital, Oslo, Norway.

Andreas Beilhack (A)

Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

Maureen E Lynch (ME)

Department of Mechanical Engineering, University of Colorado, Boulder, Colorado, USA.

Franziska Jundt (F)

Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; Comprehensive Cancer Center Mainfranken, Würzburg, Germany. Electronic address: Jundt_f@ukw.de.

Bettina M Willie (BM)

Research Centre, Shriners Hospital for Children-Canada, Montreal, Canada; Julius Wolff Institute and Berlin-Brandenburg Center for Regenerative Therapies, Charité Universitätsmedizin Berlin, Berlin, Germany; Department of Pediatric Surgery, McGill University, Montreal, Canada. Electronic address: bwillie@shriners.mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH